GlassScriptPhysician profile
Andrew J Dublin
NPI 1215085246
$59,242.22
in general payments reported to CMS, 2019-2025
53 companies · $2,255 in 2025
The $2,255 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,691 · 2020: $6,374 · 2021: $21K · 2022: $12K · 2023: $8,549 · 2024: $3,316 · 2025: $2,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,250 · Food and Beverage: $6,719 · Travel and Lodging: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,250.00 |
| Food and Beverage | $6,719.42 |
| Travel and Lodging | $150.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18,580.56 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $17,119.28 | 2019-2025 | Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,826.47 | 2019-2025 | Lifevest |
| Cathworks, INC. | $2,689.27 | 2019-2021 | |
| Boston Scientific Corporation | $1,481.18 | 2019-2025 | Watchman Flx, Watchman Access System, Vigilant X4 Crt-D |
| Abbott Laboratories | $1,000.69 | 2019-2025 | Triclip, Amplatzer Amulet, Gallant |
| Amgen INC. | $846.30 | 2019-2025 | Repatha, Repatha |
| Aop Health US, LLC | $812.06 | 2025 | Rapiblyk |
| Biotronik INC. | $756.87 | 2019-2024 | Biomonitor, Solia, Edora 8 Dr-T |
| Boehringer Ingelheim Pharmaceuticals, INC. | $646.38 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $593.57 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $538.52 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $494.49 | 2019-2023 | |
| Abiomed | $405.52 | 2019-2025 | Impella |
| Shockwave Medical, INC | $399.25 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $380.37 | 2019-2025 | Ffrct |
| Esperion Therapeutics, INC. | $319.33 | 2021-2025 | Nexletol |
| Philips North America LLC | $299.96 | 2024-2025 | (5044) Mcot, Mcot, Igt Devices Systems Undivided |
| Amarin Pharma, INC. | $297.91 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $250.37 | 2019-2024 | |
| Medtronic, INC. | $225.05 | 2021-2025 | Affera Mapping System, Onyx Frontier, Ffrangio |
| Atricure, INC. | $221.85 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $190.26 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $155.89 | 2024 | |
| Novo Nordisk INC | $150.94 | 2023-2024 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $144.99 | 2022-2025 | Verquvo, Winrevair |
| Kiniksa Pharmaceuticals International, Plc | $137.47 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $124.01 | 2022-2023 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $96.56 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $89.27 | 2023 | Arcalyst |
| Lundbeck LLC | $83.06 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.25 | 2022-2025 | |
| Cordis US Corp. | $78.98 | 2025 | Mynx Control Venous, Mynxgrip |
| Actelion Pharmaceuticals US, INC. | $77.31 | 2022-2024 | Uptravi, Opsumit |
| Cvrx, INC. | $68.32 | 2024-2025 | Barostim Neo System |
| Bardy Diagnostics, INC. | $64.58 | 2021 | |
| Elutia, INC. | $58.99 | 2019 | |
| Irhythm Technologies, INC. | $58.60 | 2019-2024 | Zio Xt Patch |
| Kestra Medical Technology Services, INC. | $57.97 | 2022-2024 | Assure Wcd |
| Akcea Therapeutics, INC. | $54.55 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $48.30 | 2022-2023 | Amvuttra |
| Glaxosmithkline, LLC. | $38.27 | 2021-2025 | Shingrix |
| Inari Medical, INC. | $37.56 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $36.27 | 2021 | |
| Siemens Medical Solutions USA, INC. | $24.10 | 2024 | Artis Icono Biplane |
| Biogen, INC. | $23.69 | 2024 | Skyclarys |
| Terumo Medical Corporation | $18.42 | 2023 | Heartrail |
| Scpharmaceuticals INC. | $17.72 | 2025 | |
| Asahi Intecc USA, INC. | $14.31 | 2022 | |
| Edwards Lifesciences Corporation | $13.34 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Baxter Healthcare | $12.99 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Dublin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.